The Department of Veterans Affairs (VA) National Acquisition Center plans to issue an unrestricted Request for Proposal (RFP) 36E79726R0007 for Nicotine Mini Lozenges. This contract will supply the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS) with an uninterrupted source of nicotine mini lozenges. The contract will be for one year with four one-year option periods, distributing items through the VA and DOD Pharmaceutical Prime Vendor Programs. Offerors must provide the exact drug name and a unique NDC number. The solicitation will be issued electronically around December 18, 2025, with a tentative closing date of January 1, 2026, on sam.gov. The NAICS code for this procurement is 325412. Estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges. Billy Fong is the point of contact for inquiries.

This government solicitation, 36E79726R0007, from the Department of Veterans Affairs, outlines a contract for Nicotine Polacrilex Mini Lozenges. The contract establishes a supply source for VA, DoD, IHS, and BOP facilities through Pharmaceutical Prime Vendor (PPV) Programs. It details requirements for pricing, including a 0.5% Cost Recovery Fee, and mandates that offerors propose prices for a base year and four option years for both 2mg and 4mg lozenges. Key provisions cover product registration with FDA, First Databank, Medispan, and Cerner Multum, as well as strict packaging and barcoding standards, including DSCSA compliance. Offerors must also provide unique 11-digit NDC/UPC numbers and hold an FDA-approved drug application. The document emphasizes the importance of maintaining an acceptable cGMP status for manufacturing facilities and outlines procedures for handling backorders and product recalls. It also addresses payment structure via PPVs, the submission of quarterly sales reports, and compliance with federal pricing for covered drugs.